Resultados de procura - Rima Al‐awar

Limitar resultados
  1. 1
    Asymmetric Synthesis of All the Known Phlegmarine Alkaloids

    Asymmetric Synthesis of All the Known Phlegmarine Alkaloids por Bradley Wolfe, Adam H. Libby, Rima Al‐awar, Christopher J. Foti, Daniel L. Comins

    Publicado 2010
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  2. 2
    Small Molecule Kinase Inhibitor Screen Identifies Polo-Like Kinase 1 as a Target for Neuroblastoma Tumor-Initiating Cells

    Small Molecule Kinase Inhibitor Screen Identifies Polo-Like Kinase 1 as a Target for Neuroblastoma Tumor-Initiating Cells por Natalie Grinshtein, Alessandro Datti, Mayumi Fujitani, David Uehling, Michaël Prakesch, Methvin Isaac, Meredith S. Irwin, Jeffrey L. Wrana, Rima Al‐awar, David R. Kaplan

    Publicado 2011
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  3. 3
    Metformin Pharmacokinetics in Mouse Tumors: Implications for Human Therapy

    Metformin Pharmacokinetics in Mouse Tumors: Implications for Human Therapy por Ryan J.O. Dowling, Sonya H.L. Lam, C. Bassi, Samar Mouaaz, Ahmed Aman, Taira Kiyota, Rima Al‐awar, Pamela J. Goodwin, Vuk Stambolic

    Publicado 2016
    Ligazón do recurso Ligazón do recurso
    Carta
    Engadir a favoritos
    Gardado en:
  4. 4
    PI3K/AKT/mTOR inhibition in combination with doxorubicin is an effective therapy for leiomyosarcoma

    PI3K/AKT/mTOR inhibition in combination with doxorubicin is an effective therapy for leiomyosarcoma por Yael Babichev, Leah Kabaroff, Alessandro Datti, David Uehling, Methvin Isaac, Rima Al‐awar, Michaël Prakesch, Ren Sun, Paul C. Boutros, Rosemarie E. Venier, Brendan C. Dickson, Rebecca Gladdy

    Publicado 2016
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  5. 5
    Bromo-deaza-SAH: A potent and selective DOT1L inhibitor

    Bromo-deaza-SAH: A potent and selective DOT1L inhibitor por Wenyu Yu, David Smil, Fengling Li, W. Tempel, O. Fedorov, Kong T. Nguyen, Yuri Bolshan, Rima Al‐awar, Stefan Knapp, C.H. Arrowsmith, Masoud Vedadi, Peter J. Brown, Matthieu Schapira

    Publicado 2013
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  6. 6
    Discovery of a Selective Inhibitor for the YEATS Domains of ENL/AF9

    Discovery of a Selective Inhibitor for the YEATS Domains of ENL/AF9 por Thomas Christott, James M. Bennett, Carmen H. Coxon, Octovia Monteiro, Charline Giroud, Viktor Beke, Suet Ling Felce, Vicki Gamble, C. Gileadi, Gennady Poda, Rima Al‐awar, Gillian Farnie, Oleg Fedorov

    Publicado 2018
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  7. 7
    A genome-wide CRISPR/Cas9 screen in acute myeloid leukemia cells identifies regulators of TAK-243 sensitivity

    A genome-wide CRISPR/Cas9 screen in acute myeloid leukemia cells identifies regulators of TAK-243 sensitivity por Samir H. Barghout, Ahmed Aman, Kazem Nouri, Zachary Blatman, Karen Arevalo, Geethu Emily Thomas, Neil MacLean, Rose Hurren, Troy Ketela, Mehakpreet Saini, Moustafa Abohawya, Taira Kiyota, Rima Al‐awar, Aaron D. Schimmer

    Publicado 2021
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  8. 8
    Gain-of-function p53 mutants co-opt chromatin pathways to drive cancer growth

    Gain-of-function p53 mutants co-opt chromatin pathways to drive cancer growth por Jiajun Zhu, Morgan A. Sammons, Greg Donahue, Zhixun Dou, Masoud Vedadi, Matthäus Getlik, Dalia Baršytė-Lovejoy, Rima Al‐awar, Bryson W. Katona, Ali Shilatifard, Jing Huang, Xianxin Hua, C.H. Arrowsmith, Shelley L. Berger

    Publicado 2015
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  9. 9
    Combined deletion of <scp>P</scp>ten and p53 in mammary epithelium accelerates triple‐negative breast cancer with dependency on e<scp>EF</scp>2<scp>K</scp>

    Combined deletion of <scp>P</scp>ten and p53 in mammary epithelium accelerates triple‐negative breast cancer with dependency on e<scp>EF</scp>2<scp>K</scp> por Jeff C. Liu, Véronique Voisin, Sharon Wang, Dong‐Yu Wang, Robert A. Jones, Alessandro Datti, David Uehling, Rima Al‐awar, Sean E. Egan, Gary D. Bader, Ming‐Sound Tsao, Tak W. Mak, Eldad Zacksenhaus

    Publicado 2014
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  10. 10
    Synthesis, Optimization, and Evaluation of Novel Small Molecules as Antagonists of WDR5-MLL Interaction

    Synthesis, Optimization, and Evaluation of Novel Small Molecules as Antagonists of WDR5-MLL Interaction por Yuri Bolshan, Matthäus Getlik, Ekaterina Kuznetsova, Gregory A. Wasney, Taraneh Hajian, Gennadiy Poda, Kong T. Nguyen, Hong Wu, L. Dombrovski, Aiping Dong, Guillermo Senisterra, Matthieu Schapira, C.H. Arrowsmith, Peter J. Brown, Rima Al‐awar, Masoud Vedadi, David Smil

    Publicado 2013
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  11. 11
    Potent Targeting of the STAT3 Protein in Brain Cancer Stem Cells: A Promising Route for Treating Glioblastoma

    Potent Targeting of the STAT3 Protein in Brain Cancer Stem Cells: A Promising Route for Treating Glioblastoma por Sina Haftchenary, H. Artee Luchman, Andriana O. Jouk, Anthony J. Veloso, Brent D. G. Page, Xin Cheng, Sean S.H. Dawson, Natalie Grinshtein, Vijay Shahani, Kağan Kerman, David R. Kaplan, Carly Griffin, Ahmed Aman, Rima Al‐awar, Samuel Weiss, Patrick T. Gunning

    Publicado 2013
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  12. 12
    Virus-Tumor Interactome Screen Reveals ER Stress Response Can Reprogram Resistant Cancers for Oncolytic Virus-Triggered Caspase-2 Cell Death

    Virus-Tumor Interactome Screen Reveals ER Stress Response Can Reprogram Resistant Cancers for Oncolytic Virus-Triggered Caspase-2 Cell Death por Douglas J. Mahoney, Charles Lefebvre, Kristina J. Allan, J Brun, Cina A. Sanaei, Stephen Baird, Nelson Pearce, S. A.‐M. Grönberg, Brian C. Wilson, Mikael Prakesh, Ahmed Aman, Methvin Isaac, Ahmed Mamai, David Uehling, Rima Al‐awar, Theresa Falls, Tommy Alain, David F. Stojdl

    Publicado 2011
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  13. 13
    Small molecule epigenetic screen identifies novel EZH2 and HDAC inhibitors that target glioblastoma brain tumor-initiating cells

    Small molecule epigenetic screen identifies novel EZH2 and HDAC inhibitors that target glioblastoma brain tumor-initiating cells por Natalie Grinshtein, Constanza Rioseco, Richard Marcellus, David Uehling, Ahmed Aman, Xueqing Lun, Osamu Muto, Lauren Podmore, Jake Lever, Yaoqing Shen, Michael Blough, G. Cairncross, Stephen M. Robbins, Steven J.M. Jones, Marco A. Marra, Rima Al‐awar, Donna L. Senger, David R. Kaplan

    Publicado 2016
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  14. 14
    MYC Interacts with the G9a Histone Methyltransferase to Drive Transcriptional Repression and Tumorigenesis

    MYC Interacts with the G9a Histone Methyltransferase to Drive Transcriptional Repression and Tumorigenesis por William B. Tu, Yu-Jia Shiah, Corey Lourenco, Peter J. Mullen, Dharmendra Dingar, Cornelia Redel, Aaliya Tamachi, Wail Ba-Alawi, Ahmed Aman, Rima Al‐awar, David W. Cescon, Benjamin Haibe‐Kains, C.H. Arrowsmith, Brian Raught, Paul C. Boutros, Linda Z. Penn

    Publicado 2018
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  15. 15
    Interrogation of Functional Cell-Surface Markers Identifies CD151 Dependency in High-Grade Serous Ovarian Cancer

    Interrogation of Functional Cell-Surface Markers Identifies CD151 Dependency in High-Grade Serous Ovarian Cancer por Mauricio Medrano, Laudine Communal, Kevin R. Brown, Marcin Iwanicki, Josée Normand, Joshua Paterson, Fabrice Sircoulomb, Paul M. Krzyzanowski, Marián Novak, Sasha A. Doodnauth, Fernando Suárez, Jane Cullis, Rima Al‐awar, Benjamin G. Neel, John D. McPherson, Ronny Drapkin, Laurie Ailles, Anne‐Marie Mes‐Masson, Robert Rottapel

    Publicado 2017
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  16. 16
    Small-molecule inhibition of MLL activity by disruption of its interaction with WDR5

    Small-molecule inhibition of MLL activity by disruption of its interaction with WDR5 por Guillermo Senisterra, Hong Wu, Abdellah Allali‐Hassani, Gregory A. Wasney, Dalia Baršytė-Lovejoy, L. Dombrovski, Aiping Dong, Kong T. Nguyen, David Smil, Yuri Bolshan, Taraneh Hajian, Hao He, Alma Seitova, Irene Chau, Fengling Li, Gennadiy Poda, Jean‐François Couture, Peter J. Brown, Rima Al‐awar, Matthieu Schapira, C.H. Arrowsmith, Masoud Vedadi

    Publicado 2012
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  17. 17
    Wnt Inhibitor Screen Reveals Iron Dependence of β-Catenin Signaling in Cancers

    Wnt Inhibitor Screen Reveals Iron Dependence of β-Catenin Signaling in Cancers por Siyuan Song, Tania Christova, Stephen Perusini, Solmaz Alizadeh, Ren-Yue Bao, Bryan W. Miller, Rose Hurren, Yulia Jitkova, Marcela Gronda, Methvin Isaac, Babu Joseph, Ratheesh Subramaniam, Ahmed Aman, Anh Chau, Donna E. Hogge, Scott J. Weir, James M. Kasper, Aaron D. Schimmer, Rima Al‐awar, Jeffrey L. Wrana, Liliana Attisano

    Publicado 2011
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  18. 18
    Discovery of Small-Molecule Antagonists of the PWWP Domain of NSD2

    Discovery of Small-Molecule Antagonists of the PWWP Domain of NSD2 por Renato Ferreira de Freitas, Yanli Liu, Magdalena M. Szewczyk, Naimee Mehta, Fengling Li, David McLeod, Carlos Zepeda‐Velázquez, David Dilworth, Ronan P. Hanley, Elisa Gibson, Peter J. Brown, Rima Al‐awar, Lindsey I. James, C.H. Arrowsmith, Dalia Baršytė-Lovejoy, Jinrong Min, Masoud Vedadi, Matthieu Schapira, Abdellah Allali‐Hassani

    Publicado 2020
    Ligazón do recurso Ligazón do recurso
    Pré-impressão
    Engadir a favoritos
    Gardado en:
  19. 19
    Discovery of Small-Molecule Antagonists of the PWWP Domain of NSD2

    Discovery of Small-Molecule Antagonists of the PWWP Domain of NSD2 por Renato Ferreira de Freitas, Yanli Liu, Magdalena M. Szewczyk, Naimee Mehta, Fengling Li, David McLeod, Carlos Zepeda‐Velázquez, David Dilworth, Ronan P. Hanley, Elisa Gibson, Peter J. Brown, Rima Al‐awar, Lindsey I. James, C.H. Arrowsmith, Dalia Baršytė-Lovejoy, Jinrong Min, Masoud Vedadi, Matthieu Schapira, Abdellah Allali‐Hassani

    Publicado 2021
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  20. 20
    Structure and mechanism of action of the hydroxy–aryl–aldehyde class of IRE1 endoribonuclease inhibitors

    Structure and mechanism of action of the hydroxy–aryl–aldehyde class of IRE1 endoribonuclease inhibitors por Mário Sanches, Nicole M. Duffy, Manisha Talukdar, N. Thevakumaran, David Chiovitti, Marella D. Canny, Kenneth Lee, Igor Kurinov, David Uehling, Rima Al‐awar, Gennadiy Poda, Michaël Prakesch, Brian J. Wilson, Victor Tam, Colleen Schweitzer, András Toró, Julie L. Lucas, D Vuga, Lynn Lehmann, Daniel Durocher, Qingping Zeng, John B. Patterson, Frank Sicheri

    Publicado 2014
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:

Ferramentas de procura: